IL17A and rheumatoid arthritis: IL-17 is also found at high levels in RA patients with advanced levels of joint damage [30]; it has also been shown to drive autonomous, TNF-independent erosive disease in mice [31,32] and TNF therapy is anecdotally reported to prevent erosion less effectively in RA patients with high IL-17 levels [30].